Letter to the editor response for: “Schneider LS, Kennedy RE, Cutter G. Caution in interpreting disease‐modification claims with lecanemab: selective reporting and causal inference. Alzheimer's & Dementia . 2026”

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.